Tenax Therapeutics Stock Probability of Future Stock Price Finishing Over 4.14

TENX Stock  USD 6.30  0.26  4.30%   
Tenax Therapeutics' future price is the expected price of Tenax Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Tenax Therapeutics performance during a given time horizon utilizing its historical volatility. Check out Tenax Therapeutics Backtesting, Tenax Therapeutics Valuation, Tenax Therapeutics Correlation, Tenax Therapeutics Hype Analysis, Tenax Therapeutics Volatility, Tenax Therapeutics History as well as Tenax Therapeutics Performance.
For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.
  
At this time, Tenax Therapeutics' Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 0.71 in 2024, whereas Price Earnings Ratio is likely to drop (0.74) in 2024. Please specify Tenax Therapeutics' target price for which you would like Tenax Therapeutics odds to be computed.

Tenax Therapeutics Target Price Odds to finish over 4.14

The tendency of Tenax Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 4.14  in 90 days
 6.30 90 days 4.14 
about 53.82
Based on a normal probability distribution, the odds of Tenax Therapeutics to stay above $ 4.14  in 90 days from now is about 53.82 (This Tenax Therapeutics probability density function shows the probability of Tenax Stock to fall within a particular range of prices over 90 days) . Probability of Tenax Therapeutics price to stay between $ 4.14  and its current price of $6.3 at the end of the 90-day period is about 53.61 .
Given the investment horizon of 90 days Tenax Therapeutics has a beta of 0.77. This usually implies as returns on the market go up, Tenax Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Tenax Therapeutics will be expected to be much smaller as well. Additionally Tenax Therapeutics has an alpha of 0.6864, implying that it can generate a 0.69 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Tenax Therapeutics Price Density   
       Price  

Predictive Modules for Tenax Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Tenax Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
2.866.299.72
Details
Intrinsic
Valuation
LowRealHigh
2.565.999.42
Details
4 Analysts
Consensus
LowTargetHigh
5.015.506.11
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-1.56-0.57-0.15
Details

Tenax Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Tenax Therapeutics is not an exception. The market had few large corrections towards the Tenax Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Tenax Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Tenax Therapeutics within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.69
β
Beta against Dow Jones0.77
σ
Overall volatility
0.73
Ir
Information ratio 0.19

Tenax Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Tenax Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Tenax Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Tenax Therapeutics appears to be risky and price may revert if volatility continues
Tenax Therapeutics has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (7.71 M) with profit before overhead, payroll, taxes, and interest of 0.
Tenax Therapeutics currently holds about 7.23 M in cash with (5.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29.
Tenax Therapeutics has a frail financial position based on the latest SEC disclosures
Latest headline from thelincolnianonline.com: Vestal Point Capital LP Acquires Shares of 83,333 Tenax Therapeutics, Inc.

Tenax Therapeutics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Tenax Stock often depends not only on the future outlook of the current and potential Tenax Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tenax Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding248.4 K
Cash And Short Term Investments9.8 M

Tenax Therapeutics Technical Analysis

Tenax Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Tenax Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Tenax Therapeutics. In general, you should focus on analyzing Tenax Stock price patterns and their correlations with different microeconomic environments and drivers.

Tenax Therapeutics Predictive Forecast Models

Tenax Therapeutics' time-series forecasting models is one of many Tenax Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Tenax Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Tenax Therapeutics

Checking the ongoing alerts about Tenax Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Tenax Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Tenax Therapeutics appears to be risky and price may revert if volatility continues
Tenax Therapeutics has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (7.71 M) with profit before overhead, payroll, taxes, and interest of 0.
Tenax Therapeutics currently holds about 7.23 M in cash with (5.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29.
Tenax Therapeutics has a frail financial position based on the latest SEC disclosures
Latest headline from thelincolnianonline.com: Vestal Point Capital LP Acquires Shares of 83,333 Tenax Therapeutics, Inc.

Additional Tools for Tenax Stock Analysis

When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.